tiprankstipranks
Trending News
More News >
Concentra Group Holdings Parent, Inc. (CON)
NYSE:CON
US Market

Concentra Group Holdings Parent, Inc. (CON) Earnings Dates, Call Summary & Reports

Compare
170 Followers

Earnings Data

Report Date
May 13, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.33
Last Year’s EPS
0.3
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 09, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: double-digit headline revenue growth, meaningful volume and rate gains, adjusted EBITDA expansion, robust free cash flow and validation of clinical outcomes. Management also highlighted successful integration of acquisitions and a sizable de novo/M&A pipeline with a 2026 guidance band that targets continued growth and ~20% adjusted EBITDA margin. Offsetting factors include elevated investing activity and one-time integration/separation costs, a higher G&A run-rate from separation, increased financing costs and a net leverage ratio (3.4x) above the company target of ~3.0x. Organic growth excluding acquisitions was more moderate, and certain state reimbursement dynamics (e.g., New York) limit expansion opportunities until rates improve. On balance, positive operational execution and financial performance materially outweigh the near-term and transitional headwinds.
Company Guidance
The company’s full‑year 2026 guidance calls for revenue of $2.25–$2.35 billion, adjusted EBITDA of $450–$470 million, CapEx of $70–$80 million, free cash flow of $200–$225 million, and a year‑end net leverage target of ~3.0x (down from 3.4x at 12/31/25); key assumptions include ~3% rate growth in the Occupational Health Centers segment, low‑single‑digit visit growth excluding Nova, inclusion of the January three‑center acquisition and six de‑novo sites with executed leases (and an overall de‑novo target of 7–9 sites in 2026), adjusted EBITDA margin roughly flat at ~20%, modest incremental separation/TSA costs early in 2026 with TSA costs ramping toward zero by mid‑year, and an expected ~ $15 million decline in CapEx as one‑time Nova integration spend rolls off.
Revenue Growth — Q4 and Full Year
Total company revenue of $539.1M in Q4 2025, up 15.9% YoY from $465.0M; excluding Nova and Pivot Q4 revenue was $493.8M (+6.2% YoY). Full year 2025 revenue of $2.2B, up 13.9% YoY from $1.9B; excluding acquisitions full year revenue was $2.0B (+6.4% YoY; +6.8% on a per-day basis).
Strong Volume Trends
Total patient visits per day increased 9.0% in Q4 to >51,000; workers' compensation visits +9.1% and employer services visits +9.4% in Q4. Full year visits per day rose 7.7% to >53,000; excluding Nova full-year visits per day increased 2.2%.
Rate Improvements
Revenue per visit grew 3.1% in Q4 (workers' compensation +4.1%, employer services +1.2%). Full-year revenue per visit increased 4.3% (workers' compensation +5.3%, employer services +2.7%).
Adjusted EBITDA and Margin Expansion
Adjusted EBITDA of $95.3M in Q4 2025, up 22.9% YoY from $77.5M; adjusted EBITDA margin improved 100 bps to 17.7% in Q4. Full-year adjusted EBITDA $431.9M (+14.6% YoY) with margin expanding to 20.0% from 19.8%.
On-Site Segment Acceleration
On-Site Health Clinics revenue of $36.2M in Q4 2025, up 112% YoY driven by Pivot acquisition; excluding Pivot, On-Site organic growth was 14.6% YoY in Q4. Full-year On-Site revenue $110.2M (+72% YoY; excl Pivot +11.6%).
Cash Flow and Free Cash Flow Strength
Q4 operating cash flow $118.7M vs $93.7M prior year. Q4 free cash flow $98.6M vs $77.0M prior year; full-year free cash flow $197.8M with free cash flow conversion at 114% of net income.
Operational Efficiencies
Cost of services improved (Q4 73.9% of revenue vs 74.2% prior year; full year 71.7% vs 72.2%). Q4 adjusted G&A (ex-addbacks) was 8.5% of revenue vs 9.4% prior year, reflecting staffing and efficiency gains.
Commercial and Clinical Validation
Clinical validation: analysis of >550,000 claims (2020–2025) showing Concentra-treated claims cost 25% lower and claim duration 65 fewer days vs non-Concentra providers. Patient satisfaction metrics at all-time highs; management reports capture of expected M&A synergies and strong de novo/M&A pipeline.

Concentra Group Holdings Parent, Inc. (CON) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CON Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
0.33 / -
0.3
Mar 09, 2026
2025 (Q4)
0.23 / 0.28
0.1764.71% (+0.11)
Nov 05, 2025
2025 (Q3)
0.38 / 0.39
0.375.41% (+0.02)
Aug 07, 2025
2025 (Q2)
0.38 / 0.35
0.498-29.72% (-0.15)
May 07, 2025
2025 (Q1)
0.32 / 0.30
0.48-37.50% (-0.18)
Mar 03, 2025
2024 (Q4)
0.17 / 0.17
Oct 31, 2024
2024 (Q3)
0.35 / 0.37
Aug 01, 2024
2024 (Q2)
0.50 / 0.50
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CON Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 09, 2026
$22.51$22.38-0.58%
Nov 05, 2025
$19.03$18.60-2.24%
Aug 07, 2025
$20.03$21.44+7.03%
May 07, 2025
$21.62$20.87-3.47%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Concentra Group Holdings Parent, Inc. (CON) report earnings?
Concentra Group Holdings Parent, Inc. (CON) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
    What is Concentra Group Holdings Parent, Inc. (CON) earnings time?
    Concentra Group Holdings Parent, Inc. (CON) earnings time is at May 13, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CON EPS forecast?
          CON EPS forecast for the fiscal quarter 2026 (Q1) is 0.33.